Skip to main content
Log in

Characterization of an osteomyelitis case caused by dalbavancin, ceftaroline, and vancomycin non-susceptible methicillin-resistant Staphylococcus aureus

  • Brief Report
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

We report a case of osteomyelitis due to methicillin-resistant Staphylococcus aureus (MRSA) that is also non-susceptible to vancomycin, dalbavancin, ceftaroline, and ceftobiprole, in the absence of exposure to the latter three antibiotics. It was isolated from a patient with a 26-year history of cranial surgeries and episodes of osteomyelitis. Whole-genome sequencing was performed. It was found to belong to ST247 and the mecA gene was detected within the SSCmec type I (1B) gene cassette that lacked the E447K mutation known to produce resistance to ceftobiprole and ceftaroline. However, mutations in other genes related to resistance to these antibiotics were found.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kavanagh N, Ryan EJ, Widaa A, Sexton G et al (2018) Staphylococcal osteomyelitis: disease progression, treatment challenges, and future directions. Clin Microbiol Rev 31:e00084–e00017

    Article  CAS  Google Scholar 

  2. Calhoun JH, Manring MM, Shirtliff M (2009) Osteomyelitis of the long bones. 2015. Semin Plast Surg 23:59–72

    Article  Google Scholar 

  3. Zimmerli W, Sendi P (2017) Orthopaedic biofilm infections. APMIS 125:353–364

    Article  Google Scholar 

  4. Otero LH, Rojas-Altuve A, Llarrull LI, Carrasco-López C et al (2013) How allosteric control of Staphylococcus aureus penicillin binding protein 2a enables methicillin resistance and physiological function. Proc Natl Acad Sci U S A 110:16808–16813

    Article  Google Scholar 

  5. Chen AY, Zervos MJ, Vazquez JA (2007) Dalbavancin: a novel antimicrobial. Int J Clin Pract 61:853–863

    Article  CAS  Google Scholar 

  6. Lovering AL, Gretes MC, Safadi SS, Danel F et al (2012) Structural insights into the anti-methicillin-resistant Staphylococcus aureus (MRSA) activity of ceftobiprole. J Biol Chem 287:32096–32102

    Article  CAS  Google Scholar 

  7. Ślusarczyk R, Bielejewska A, Bociek A, Bociek M (2018) Resistance to ceftaroline - 2018 review. Eur J Biol Res 8:112/120

    Google Scholar 

  8. Kussmann M, Karer M, Obermueller M, Schmidt K et al (2018) Emergence of a dalbavancin induced glycopeptide/lipoglycopeptide non-susceptible Staphylococcus aureus during treatment of a cardiac device-related endocarditis. Emerg Microbes Infect 7:202

    Article  Google Scholar 

  9. Gostev V, Sopova J, Kalinogorskaya O, Tsvetkova I et al (2019) In vitro ceftaroline resistance selection of methicillin-resistant staphylococcus aureus involves different genetic pathways. Microb Drug Resist 25:1401–1409

    Article  CAS  Google Scholar 

  10. Campanile F, Borbone S, Perez M, Bonjiorno D et al (2010) Heteroresistance to glycopeptides in Italian meticillin-resistant Staphylococcus aureus (MRSA) isolates. Int J Antimicrob Agents 36:415–419

    Article  CAS  Google Scholar 

  11. Kleinert F, Kallies R, Zweynert A, Bierbaum G (2016) Draft genome sequences of three Northern German epidemic Staphylococcus aureus (ST247) strains containing multiple copies of IS256. Genome Announc 4:e00936–e00916

    Article  Google Scholar 

  12. Chan LC, Basuino L, Diep B, Hamilton S et al (2015) Ceftobiprole- and ceftaroline-resistant methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 59:2960–2963

    Article  CAS  Google Scholar 

  13. Bongiorno D, Mongelli G, Stefani S, Campanile F (2020) Genotypic analysis of Italian MRSA strains exhibiting low-level ceftaroline and ceftobiprole resistance. Diagn Microbiol Infect Dis 95:114852

    Google Scholar 

  14. Kim JW, Lee KJ (2020) Single-nucleotide polymorphisms in a vancomycin-resistant Staphylococcus aureus strain based on whole-genome sequencing. Arch Microbiol 202:2255. https://doi.org/10.1007/s00203-020-01906-y

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. McGuinness WA, Malachowa N, DeLeo FR (2017) Vancomycin resistance in Staphylococcus aureus. Yale J Biol Med 90:269–281

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Elias Dahdouh.

Ethics declarations

Ethics approval

Not applicable.

Informed consent

Not applicable.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

ESM 1

(DOCX 14 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dahdouh, E., Díaz-Pollán, B., Falces-Romero, I. et al. Characterization of an osteomyelitis case caused by dalbavancin, ceftaroline, and vancomycin non-susceptible methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 40, 2029–2032 (2021). https://doi.org/10.1007/s10096-021-04219-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-021-04219-0

Keywords

Navigation